Scarica l'app Stockscreener
417.84
0.40%
1.66
Pre-mercato:
420.00
2.16
+0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$416.18
Aprire:
$419.92
Volume 24 ore:
2.43M
Relative Volume:
0.92
Capitalizzazione di mercato:
$226.05B
Reddito:
$37.30B
Utile/perdita netta:
$7.80B
Rapporto P/E:
29.06
EPS:
14.3793
Flusso di cassa netto:
$8.60B
1 W Prestazione:
+3.21%
1M Prestazione:
+15.92%
6M Prestazione:
+13.18%
1 anno Prestazione:
+44.42%
Intervallo 1D:
$415.78
$420.26
Intervallo di 1 settimana:
$401.07
$421.79
Portata 52W:
$269.77
$421.79
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
417.84 | 225.15B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,209.00 | 1.09T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
262.08 | 628.65B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
250.82 | 439.59B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
135.55 | 327.94B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
151.72 | 289.52B | 54.66B | 13.58B | 16.05B | 7.0171 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Hold |
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen (AMGN) Stock Looks Below Fair Value As Caution Lingers - simplywall.st
Amgen stock holds above $417 as Q2 2026 beats drive higher guidance - AD HOC NEWS
Insider Selling: Amgen (NASDAQ:AMGN) SVP Sells $521,370.36 in Stock - MarketBeat
Insider Selling: Amgen (NASDAQ:AMGN) SVP Sells $825,140.00 in Stock - MarketBeat
Amgen SVP Rachna Khosla sells $1.35m of stock By Investing.com - Investing.com India
Amgen SVP Rachna Khosla sells $1.35m of stock - Investing.com
Amgen stock holds above $415 as strong Q2 2026 results lift guidance - AD HOC NEWS
Daiwa Securities Adjusts Price Target on Amgen to $430 From $390, Keeps Outperform Rating - marketscreener.com
Barclays Adjusts Price Target on Amgen to $380 From $360, Maintains Equalweight Rating - marketscreener.com
Amgen stock holds near a yearly high after Q2 beats - AD HOC NEWS
Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Is Amgen (AMGN) Fully Valued On Strong Q2 Results And Raised 2026 Guidance? - simplywall.st
CEO Bob Bradway’s Advice to the Next Generation of Innovators - Amgen
Does Amgen (NASDAQ:AMGN) Fit Into The Biotech and Biosimilar Story? - Kalkine Media
Amgen Stock And The Price Of A Promise - trefis.com
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment - WSJ
Amgen stock trades near a yearly high after Q2 beats - AD HOC NEWS
Tema ETFs LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
G&S Capital LLC Makes New $1.58 Million Investment in Amgen Inc. $AMGN - MarketBeat
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD - PR Newswire
Amgen (AMGN) Q2 2026 Earnings Call Transcript - AOL.com
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - benzinga.com
Amgen (NASDAQ:AMGN) Hits New 1-Year HighHere's Why - MarketBeat
Handelsbanken Fonder AB Has $125.51 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by KMG Fiduciary Partners LLC - MarketBeat
Charles Schwab Trust Co Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) director Charles Holley receives stock award and reports trust holdings - Stock Titan
Amgen (AMGN) director Michael V. Drake granted 63.8764 shares in equity award - Stock Titan
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Guggenheim raises Amgen stock price target to $388 on strong quarter - Investing.com Canada
Amgen Inc. (AMGN) Stock Analysis: Navigating a Strong Market Cap with High Return on Equity - DirectorsTalk Interviews
AMGEN INC : HSBC RAISES TARGET PRICE TO $445 FROM $425 - Bitget
AMGEN INC : GUGGENHEIM RAISES TARGET PRICE TO $388 FROM $343 - Bitget
Erste Group Bank Brokers Lower Earnings Estimates for Amgen - MarketBeat
Amgen Stock Jumped 8% This Week After a Guidance Raise. Here’s What’s Next - TIKR.com
Amgen Inc. (AMGN) Stock forecasts - Yahoo Finance UK
Avity Investment Management Inc. Has $27.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Cardano Risk Management B.V. Sells 14,358 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Just Recorded A 17% EPS Beat: Here's What Analysts Are Forecasting Next - 富途牛牛
MRA Advisory Group Grows Holdings in Amgen Inc. $AMGN - MarketBeat
Teamwork Financial Advisors LLC Sells 8,835 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMG) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Assenagon Asset Management S.A. Has $69.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Abner Herrman & Brock LLC Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Amgen SVP & CCO Nancy Grygiel disposes of $1.19m in stock - Investing.com
Amgen Inc. Stock 12‑Month Price Target Raised to $378.67, Implies 6% Downside - TradingView
Insider Selling: Amgen (NASDAQ:AMGN) SVP Sells 2,970 Shares of Stock - MarketBeat
Amgen: The Market Is Underestimating Its Next Growth Phase (NASDAQ:AMGN) - Seeking Alpha
Amgen Inc. $AMGN Shares Acquired by Czech National Bank - MarketBeat
Sarasin & Partners LLP Cuts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amgen Inc Azioni (AMGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Khosla Rachna | SVP, Business Development |
Aug 11 '26 |
Sale |
412.57 |
2,000 |
825,134 |
6,404 |
| Khosla Rachna | SVP, Business Development |
Aug 13 '26 |
Sale |
416.43 |
1,252 |
521,365 |
6,404 |
0.79%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):